Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Victor de LedinghenJean-Michel Pawlotsky

Abstract

Failure to achieve sustained virological response (SVR) with hepatitis C virus (HCV) direct-acting antiviral (DAA)-based regimens is commonly associated with emergence of resistance-associated substitutions (RASs). Retreatment of patients who failed prior DAAs remains challenging. The aim of this prospective and randomized study was to evaluate the efficacy (primary endpoint: SVR 12 weeks after end of treatment [SVR12]) and safety of sofosbuvir + grazoprevir/elbasvir + ribavirin for 16 or 24 weeks in patients who had failed to achieve SVR on previous NS5A- or NS3-based therapy and with evidence of RASs at failure. Patients were chronically infected with HCV genotype 1 or 4. Most of them had advanced fibrosis or compensated cirrhosis (liver stiffness 5.8-48.8 kPa). All patients achieved HCV RNA below the lower limit of quantification (either target detected [unquantifiable] or target not detected) during treatment. SVR12 was achieved by 25 of 26 patients. The only patient who did not reach SVR was a patient who died, but HCV RNA was negative at this time (5 weeks after stopping treatment). No patient discontinued treatment because of adverse events or virological failure. Globally, treatment was well tolerated. Our findings supp...Continue Reading

References

Feb 9, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christophe HézodeJean-Michel Pawlotsky
Sep 27, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
Jan 28, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadFederico J Mensa
Feb 22, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric LawitzJulio Gutierrez
Jun 1, 2017·The New England Journal of Medicine·Marc BourlièreUNKNOWN POLARIS-1 and POLARIS-4 Investigators

❮ Previous
Next ❯

Citations

Oct 13, 2018·Expert Review of Clinical Pharmacology·Fabrizio Fabrizi, Piergiorgio Messa
Apr 23, 2019·Current Opinion in Organ Transplantation·Meghan E SiseRaymond T Chung
May 23, 2019·Clinical Pharmacokinetics·Elise J SmoldersDavid M Burger
Jul 30, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Timothy PapalucaAlexander Thompson
May 13, 2020·Journal of Viral Hepatitis·Julia DietzUNKNOWN European HCV Resistance Study Group
Mar 20, 2020·Clinical and Molecular Hepatology·Chung-Feng Huang, Ming-Lung Yu
May 6, 2020·PloS One·Felix PiechaJulian Schulze Zur Wiesch
May 16, 2019·Current Opinion in Organ Transplantation·Meghan E SiseRaymond T Chung
Jun 10, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Haley PritchardHarrys A Torres
Jul 9, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David WylesUNKNOWN C-CREST Part C and C-SURGE Investigators
Oct 13, 2018·World Journal of Hepatology·Heidar Sharafi, Seyed Moayed Alavian
Jan 12, 2021·Expert Review of Anti-infective Therapy·Szu-Jen WangMing-Lung Yu
Nov 11, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Julia DietzUNKNOWN European HCV Resistance Study Group
May 2, 2020·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ming-Lung YuWan-Long Chuang
Mar 16, 2021·Journal of Hepatology·Christoph Sarrazin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.